Étude interventionnelle sur le dolutégravir et les autres antirétroviraux dans l’athérosclérosclérose infra-clinique en milieu hospitalier de Kinshasa

INTRODUCTION: After 2016, the World Health Organization (WHO) proposed Dolutegravir (DTG) as an alternative first-line treatment for adults. Thus, the purpose of this study was to identify biomarkers of cardiometabolic risk capable of demonstrating the beneficial effect of Dolutegravir (DTG) compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Mashi, Murielle Longokolo, Mambimbi, Marcel Mbula, Situakibanza, Hippolyte Nani-Tuma, Ndona, Madone Mandina, Risassi, Jean-Robert Makulo, Ngongo, Nadine Mayasi, Bepouka, Ben, Ossam, Odio, Tshibola, Jean Mukaya, Tshienda, Frédéric Tshibasu, Kasongo, Eric Mukenge, Nzita, Mamy Ngole, Tuna, Lukiana, Lulebo, Aimée, Sonzi, Donatien Mangala, Lusunsi, Christian Kisoka, Longo-Mbenza, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460102/
https://www.ncbi.nlm.nih.gov/pubmed/37637394
http://dx.doi.org/10.11604/pamj.2023.45.63.39461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460102/
https://www.ncbi.nlm.nih.gov/pubmed/37637394
http://dx.doi.org/10.11604/pamj.2023.45.63.39461

Ejemplares similares